• Anti-TNF decreases risk for penetrating complication in pediatric Crohn's

    2 days ago - By Healio

    Among pediatric patients with Crohn's disease and ulcerative colitis, the risk for incidence of intestinal resection and colectomy after 5 years of diagnosis decreased over a 24-year period, according to a presenter at UEG Week.
    “The aim of the present study was to gain more insight into the impacts of immunosuppressants and anti-tumor necrosis introduction on long-term disease outcomes in a large, population-based pediatric cohort,” Delphine Ley, MD, PhD, of the INSERM unit at the University of Lille and the department of pediatrics at Lille University Hospital in France,
    Read more ...

     

  • Bispecific Antibody Compares Favorably With Anti-VEGF for Retinal Disease

    Bispecific Antibody Compares Favorably With Anti-VEGF for Retinal Disease

    2 days ago - By MedPageToday

    SAN ANTONIO - The bispecific antibody faricimab performed at least as well as standard anti-VEGF therapy for age-related macular degeneration and diabetic macular edema with increased durability, data from four...
    Read more ...

     

  • Crohn's Disease: No Decline in Stomas With Anti-TNF Therapy

    Crohn's Disease: No Decline in Stomas With Anti-TNF Therapy

    2 days ago - By Medscape

    Despite the increasing use of anti-TNF medications and a low rate of proctectomy, a recent analysis finds no decline in stoma incidence among patients.
    Medscape Medical News
    Read more ...